Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study
Consumers prefer using digital tools for reporting ADRs and place high value on features such as a free-text space for describing ADRs, acknowledgement of report submissions, and access to summaries of previously submitted reports.
Authors
- Lisa M. Kalisch Ellett (ORCID: https://orcid.org/0000-0001-5063-6128)
- Renly Lim (ORCID: https://orcid.org/0000-0003-4135-2523)
- Elizabeth E. Roughead (ORCID: https://orcid.org/0000-0002-6811-8991)
- Eyob Alemayehu Gebreyohannes (ORCID: https://orcid.org/0000-0002-0075-4553)
- Gizat M. Kassie (ORCID: https://orcid.org/0000-0003-4286-3771)
- Mohammed Gebre Dedefo (ORCID: https://orcid.org/0000-0003-2262-0158)
- Nava Nikpay Salekdeh
Institutions
- University of South Australia (AU)
Publication Details
- Journal
- International Journal of Clinical Pharmacy
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1007/s11096-024-01847-2
- Citations
- 2
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- University of South Australia
- National Health and Medical Research Council
- National Medical Research Council